Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health. It develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases.

Biotechnology

Health Care

Pharmaceutical

Therapeutics

Causeway Therapeutics

Causeway Therapeutics' headquarters in Glasgow, United Kingdom

Derek Gilchrist

Jonathan Doogan

David Armour

Neal L Millar

Neil Gibson

Iain B McInnes

George AC Murrell

Declan Doogan

Chris Jones

Gregor Cardow

The Advisory & Directorial Team at Causeway Therapeutics provides strategic guidance and oversight for the company's clinical-stage biopharmaceutical initiatives. They ensure that development and clinical trials of novel microRNA therapies align with both regulatory standards and the company’s long-term objectives in treating musculoskeletal and age-related diseases.

Advisory & Directorial Team

The Leadership Team at Causeway Therapeutics oversees the strategic direction, financial management, medical initiatives, and commercial strategies of the company. Comprising the Co-founder & CEO, CFO, Co-founder & Chief Medical Officer, and Chief Strategy & Commercial Officer (SVP), this team ensures the successful development and implementation of innovative microRNA therapies for musculoskeletal and age-related diseases.

Leadership Team

Causeway Therapeutics

Org chart

Board & advisors

Teams

Advisory & Directorial Team

Leadership Team

Offices

Causeway Therapeutics

Org chart

Board & advisors

Teams

Advisory & Directorial Team

Leadership Team

Offices

Related companies